Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

BBNXBBNX
6 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in BETA BIONICS INC

JPMORGAN CHASE & CO holds 703,356 shares of BBNX (BETA BIONICS INC), worth $12M as of 2026-Q2. The position was increased (+128.9% shares). BBNX represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$12M

Current Shares

703,356

Total Value Change

+$11.9M

Total Shares Change

+697,096

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
703,356
+128.9%
$12M0.0%$15.67
45
2026-Q1
Decreased
307,229
-11.9%
$3M0.0%$11.57
0
2025-Q4
Decreased
348,671
-15.3%
$10.6M0.0%$31.97
0
2025-Q3
Increased
411,910
+6576.0%
$8.2M0.0%$19.85
44
2025-Q2
Decreased
6,170
-1.4%
$89,8360.0%$15.07
0
2025-Q1
New
6,260
-
$76,6220.0%$11.71
33

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used